- Home
- NBTX vs SLND Comparison
NBTX vs SLND Comparison
Compare NBTX & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- SLND
- Stock Information
- Founded
- NBTX 2003
- SLND 1900
- Country
- NBTX France
- SLND United States
- Employees
- NBTX N/A
- SLND N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- SLND Military/Government/Technical
- Sector
- NBTX Health Care
- SLND Industrials
- Exchange
- NBTX Nasdaq
- SLND Nasdaq
- Market Cap
- NBTX 178.7M
- SLND 175.8M
- IPO Year
- NBTX 2020
- SLND N/A
- Fundamental
- Price
- NBTX $3.29
- SLND $3.17
- Analyst Decision
- NBTX Strong Buy
- SLND Strong Buy
- Analyst Count
- NBTX 1
- SLND 1
- Target Price
- NBTX $8.00
- SLND $5.00
- AVG Volume (30 Days)
- NBTX 11.4K
- SLND 38.8K
- Earning Date
- NBTX 04-02-2025
- SLND 05-12-2025
- Dividend Yield
- NBTX N/A
- SLND N/A
- EPS Growth
- NBTX N/A
- SLND N/A
- EPS
- NBTX N/A
- SLND N/A
- Revenue
- NBTX N/A
- SLND $980,179,000.00
- Revenue This Year
- NBTX N/A
- SLND $4.06
- Revenue Next Year
- NBTX $277.81
- SLND $7.16
- P/E Ratio
- NBTX N/A
- SLND N/A
- Revenue Growth
- NBTX N/A
- SLND N/A
- 52 Week Low
- NBTX $2.76
- SLND $1.85
- 52 Week High
- NBTX $7.51
- SLND $5.98
- Technical
- Relative Strength Index (RSI)
- NBTX 46.34
- SLND 51.95
- Support Level
- NBTX $3.28
- SLND $3.01
- Resistance Level
- NBTX $3.53
- SLND $3.32
- Average True Range (ATR)
- NBTX 0.18
- SLND 0.18
- MACD
- NBTX 0.00
- SLND 0.02
- Stochastic Oscillator
- NBTX 46.48
- SLND 76.56
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.